High Risk Treatment Of Multiple Sclerosis Discovered By Canadian Doctors


Treatment Of Multiple Sclerosis

Multiple Sclerosis, or Treatment Of Multiple Sclerosis, is among the most common chronic inflammatory diseases of the central nervous system, affecting an estimated 2 million people worldwide. Symptoms of multiple sclerosis can include extreme fatigue, lack of coordination, numbness or tingling, bladder problems, cognitive impairment, tremors, mood changes, and weakness, among others, and can vary greatly from person to person.
 Last year, research led by two Canadian doctors from Ottawa, Ontario, and published in The Lancet medical journal, revealed that a high-risk therapy may be able to stop the disease from progressing further.“This is the first Treatment Of Multiple Sclerosis to produce this level of disease control or neurological recovery” from multiple sclerosis, the journal said in a news release, but researchers also admit the procedure may be too risky to offer multiple sclerosis sufferers, as one out of the 24 patients involved in the clinical trial died from liver failure.

The Results Are Impressive: Despite this fact, the results are impressive. In the journal’s accompanying editorial, a German doctor marvelled at the treatment’s efficacy, noting that it’s the “first trial ever that showed complete suppression of any inflammatory disease actively in every single patient for a prolonged period.”This editorial also says that, for the time being, the Treatment Of Multiple Sclerosis should be restricted to specialized centres, warning that “all efforts must be taken to avoid stem cell tourism.